Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current concepts on vaccinations in multiple sclerosis].

F Zipp1, K P Wandinger

  • 1AG Klinische Neuroimmunologie, Neurologische Klinik und Poliklinik, Universitätsklinikum Charité Berlin.

Der Nervenarzt
|November 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitis" [Eur. J. Paediatr. Neurol. 47 (2023) 118-130].

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitis.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2024
Same author

Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis.

Multiple sclerosis and related disorders·2019
Same author

[New aspects of immunotherapy in multiple sclerosis].

Der Nervenarzt·2018
Same author

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

European journal of neurology·2018
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Vaccinations, including hepatitis B, do not increase the risk of developing multiple sclerosis (MS). Furthermore, existing MS cases are not worsened by common vaccinations like hepatitis B, tetanus, or influenza.

Area of Science:

  • Immunology
  • Neurology
  • Epidemiology

Context:

  • Concerns have been raised regarding potential links between vaccinations and adverse neurologic events, specifically multiple sclerosis (MS).
  • The possibility exists that infectious agents or vaccines might trigger or exacerbate MS pathogenesis.
  • Recent immunological findings suggest a single T cell can recognize multiple antigens, raising questions about vaccine-induced autoimmunity.

Purpose:

  • To investigate the potential association between hepatitis B vaccination and the risk of developing multiple sclerosis (MS).
  • To determine if hepatitis B, tetanus, or influenza vaccinations impact the course of established multiple sclerosis.

Summary:

  • Recent epidemiologic studies indicate that hepatitis B vaccination does not elevate the risk of MS development.

Related Experiment Videos

  • The progression or severity of multiple sclerosis is not negatively affected by hepatitis B, tetanus, or influenza vaccinations.

    • Impact:

    • Provides evidence-based reassurance to the public and healthcare professionals regarding vaccine safety in relation to MS.
    • Helps to clarify the relationship between vaccination and autoimmune neurological disorders, potentially informing future public health policies.